Insurance companies may cover weight loss medications, but they are not required to cover them, so this is not always the case
[3] Katturajan R, Evan Prince S
GLP-1 RAs exert direct and indirect effects on the CV system including vasodilation, natriuresis anti-atherosclerotic effects, improvements in endothelial function, anti-inflammatory effects (decrease cytokines level such as tumor necrosis factor, interlukin-1, interlukin-6) and a consequent decrease in C-reactive protein, and reductions in infarct size (60, 84, 85)
The medication hit pharmacy shelves in early January
[6] Non-covalent interactions, such as hydrogen bonds and electrostatic forces, may facilitate the potential binding of GHRP-2 to the receptor